ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

ADVFN

Trade Now

EasyMarkets
Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P 500
4,558.75
(
-0.78%
)
US Tech 100
15,411.20
(
-1.2%
)
Dow Jones
36,163.57
(
-0.23%
)
Brent Oil
78.215
(
-1.76%
)
Bitcoin
41,786.28
(
4.51%
)
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Gossamer Bio Inc (GOSS)

  7. Gossamer Bio Inc (GOSS) News

GOSS Gossamer Bio Inc

0.8988
0.0528 (6.24%)
Last Updated: 13:53:19
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Gossamer Bio Inc GOSS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.0528 6.24% 0.8988 13:53:19
Open Price Low Price High Price Close Price Prev Close
0.8297 0.8297 0.93 0.846
more quote information »

Recent News

Date Time Source Heading
11/29/202316:01EDGAR2Form 8-K - Current report
11/29/202307:01BWGossamer Bio Announces Appointment of John Quisel, J.D.,..
11/27/202316:01EDGAR2Form 8-K - Current report
11/22/202319:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202319:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202319:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/17/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/14/202318:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/09/202307:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202307:31EDGAR2Form 8-K - Current report
11/09/202307:31BWGossamer Bio Announces Third Quarter 2023 Financial Results..
10/20/202316:01EDGAR2Form 8-K - Current report
10/03/202316:08BWGossamer Bio Announces Addition of Rainer Zimmermann, MD, as..
9/07/202317:00EDGAR2Form 8-K - Current report
9/07/202307:44BWGossamer Bio to Present Results of TORREY FRI Sub-Study at..
8/29/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
8/28/202316:29EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/21/202316:01EDGAR2Form DEL AM - Delaying amendment
8/18/202308:41EDGAR2Form S-3 - Registration statement under Securities Act of..
8/18/202308:38EDGAR2Form RW - Registration Withdrawal Request
8/17/202316:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
8/08/202316:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202316:01EDGAR2Form 8-K - Current report
8/08/202316:01BWGossamer Bio Announces Second Quarter 2023 Financial Results..
7/28/202315:46EDGAR2Form SC 13D - General statement of acquisition of beneficial..
7/26/202316:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/24/202316:16BWGossamer Bio to Hold Conference Call with PAH Experts to..
7/20/202316:01EDGAR2Form 8-K - Current report
7/20/202307:56BWGossamer Bio Announces $212 Million Private Placement..
7/20/202307:50EDGAR2Form 8-K - Current report
5/18/202307:05BWGossamer Bio Announces TORREY Data to be Featured at..
5/09/202316:01BWGossamer Bio Announces First Quarter 2023 Financial Results..
3/17/202307:31BWGossamer Bio Announces Fourth Quarter and Full-Year 2022..
12/08/202206:15TRMNGossamer Bio (GOSS) Gets a Buy from H.C. Wainwright
12/07/202211:25TRMNUBS Keeps Their Buy Rating on Gossamer Bio (GOSS)
12/07/202211:25TRMNGoldman Sachs Sticks to Their Buy Rating for Gossamer Bio..
12/07/202207:35TRMNSMBC Nikko downgrades Gossamer Bio (GOSS) to a Hold
12/07/202207:35TRMNGossamer Bio (GOSS) Gets a Buy from Raymond James
12/06/202214:35TRMNWedbush Keeps Their Buy Rating on Gossamer Bio (GOSS)
12/06/202211:00TRMNGossamer Bio Tanks after Phase 2 Study Results in PAH
12/06/202207:15BWGossamer Bio Announces Seralutinib Meets Primary Endpoint in..

Your Recent History

NASDAQ
GOSS
Gossamer Bio
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com